基金:国自然申请立项依据的三大忌

2015-11-02 解螺旋.小米 解螺旋,医生科研助手

国自然申请马上要提到日程上来了,其中立项依据是能否通过的关键点。因为标书后面的所有内容,几乎都在立项问题的酝酿中形成的。必须有充分体现创新性的理由,然后才是在此基础上提出研究目标、内容和方案。 写立项依据要讲究化有形为无形。立项依据是基金申请书的重点。需要逻辑清晰,条理清楚,重点突出。立项依据也不宜过长或者过短,以描述清楚本申请课题的主要背景和意义、国际/国内学术界的研究进展、本研究组的

国自然申请马上要提到日程上来了,其中立项依据是能否通过的关键点。因为标书后面的所有内容,几乎都在立项问题的酝酿中形成的。必须有充分体现创新性的理由,然后才是在此基础上提出研究目标、内容和方案。


写立项依据要讲究化有形为无形。立项依据是基金申请书的重点。需要逻辑清晰,条理清楚,重点突出。立项依据也不宜过长或者过短,以描述清楚本申请课题的主要背景和意义、国际/国内学术界的研究进展、本研究组的相关前期工作、本研究方向存在的问题以及本申请课题要研究问题以及意义即可。

立项依据有三个重要基础:一是要有与拟申请项目研究内容有关的预实验结果,二是要提供对拟研究内容的研究思路,三是有文献基础,但是往往有人把握不住重点,弄巧成拙,尤其是以下几点提醒给位注意,请尽量避免。

一忌大话空话喊口号

长期以来,部分做科研的人开始使用新闻性的方法写立项依据。如:引经据典、使用热点词汇、大量使用形容词副词等修辞、做简单化解释等。同时大谈美好前景。这一特点甚至在很多论文中都能看到。其极端形式是:假大空。

不要从“大处落墨”,不要用学科的意义来“装点”你问题的意义,也不要陈述一般性的常识,也不要写决心书,满纸“豪言壮语”,如“为科学创新做贡献”,“为科学决策提供理论基础”,等等,这些都是大话和空话!

二忌文献罗列无主次

在立项依据里,最主要的内容是对研究现状的评述。千万不要把它写成研究者的姓名和标题的罗列,如XXX做了什么课题,YYY做了什么实验,ZZZ提出了什么方法……如此罗列,给人的感觉是,你只把相关文献的检索结果摘抄下来了,谁知道读了没有,读得怎样。那样的句子,不读文献也能写出来。

要将文献中的内容融会贯通有机地变成自己的依据,只须写与你的题目相关的东西,如提出什么方法或模型,能解决什么疑难。如果哪句话能随便放进别人甚至每个人的申请书里,那句话就该删除了。

三忌逻辑混乱无主线

文献的评述,应该放在问题的逻辑框架下,而不能是随意的读书笔记。每篇文献、每句话都要切合你的问题,以问题所涉及的内容、方法、结果和遗憾等等,来组织不同的文献,让前人的研究成果自然融入你对问题的阐述中。千万不要跟着文献索引走或者跟任何一篇文献的思路走——走自己的路,让文献退避到括号里面去吧!

总之,写文献评述时,要换一种角色,即使自己是后辈或小卒,也要挺起身子来站在巨人的肩上,假装为一个大师去指点江山,让那些文章看起来只不过是为了你现在的研究而做的准备,而现在,你这位主角要出场了!

最后,还要提醒一下,立项依据最好不要有过多的层次,如一、二、三、1,2,3, abc, 1.1.2.a等等。可以用几张彩色图来烘托气氛,增强功力。要特别重视对国内同行的相关工作的介绍,最好要有详实贴切的介绍。因为你的申请书有很大的可能落到他们的手中。一句“不了解同行的工作”就可能废了你的武功。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1803680, encodeId=6b11180368043, content=<a href='/topic/show?id=2c83e563067' target=_blank style='color:#2F92EE;'>#立项依据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75630, encryptionId=2c83e563067, topicName=立项依据)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Dec 12 09:10:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42397, encodeId=68a04239e28, content=太好了,受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58701660184, createdName=docterdw123, createdTime=Tue Nov 03 10:54:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42355, encodeId=93fb4235581, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 18:13:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42330, encodeId=72be42330ee, content=难呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42331, encodeId=79804233149, content=想想科研,五味杂陈, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42332, encodeId=f4fd423329b, content=尽力吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1803680, encodeId=6b11180368043, content=<a href='/topic/show?id=2c83e563067' target=_blank style='color:#2F92EE;'>#立项依据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75630, encryptionId=2c83e563067, topicName=立项依据)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Dec 12 09:10:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42397, encodeId=68a04239e28, content=太好了,受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58701660184, createdName=docterdw123, createdTime=Tue Nov 03 10:54:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42355, encodeId=93fb4235581, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 18:13:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42330, encodeId=72be42330ee, content=难呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42331, encodeId=79804233149, content=想想科研,五味杂陈, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42332, encodeId=f4fd423329b, content=尽力吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-03 docterdw123

    太好了,受益

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1803680, encodeId=6b11180368043, content=<a href='/topic/show?id=2c83e563067' target=_blank style='color:#2F92EE;'>#立项依据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75630, encryptionId=2c83e563067, topicName=立项依据)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Dec 12 09:10:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42397, encodeId=68a04239e28, content=太好了,受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58701660184, createdName=docterdw123, createdTime=Tue Nov 03 10:54:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42355, encodeId=93fb4235581, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 18:13:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42330, encodeId=72be42330ee, content=难呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42331, encodeId=79804233149, content=想想科研,五味杂陈, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42332, encodeId=f4fd423329b, content=尽力吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 玥月

    受教

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1803680, encodeId=6b11180368043, content=<a href='/topic/show?id=2c83e563067' target=_blank style='color:#2F92EE;'>#立项依据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75630, encryptionId=2c83e563067, topicName=立项依据)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Dec 12 09:10:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42397, encodeId=68a04239e28, content=太好了,受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58701660184, createdName=docterdw123, createdTime=Tue Nov 03 10:54:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42355, encodeId=93fb4235581, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 18:13:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42330, encodeId=72be42330ee, content=难呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42331, encodeId=79804233149, content=想想科研,五味杂陈, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42332, encodeId=f4fd423329b, content=尽力吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 fatalmelanie

    难呀

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1803680, encodeId=6b11180368043, content=<a href='/topic/show?id=2c83e563067' target=_blank style='color:#2F92EE;'>#立项依据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75630, encryptionId=2c83e563067, topicName=立项依据)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Dec 12 09:10:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42397, encodeId=68a04239e28, content=太好了,受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58701660184, createdName=docterdw123, createdTime=Tue Nov 03 10:54:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42355, encodeId=93fb4235581, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 18:13:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42330, encodeId=72be42330ee, content=难呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42331, encodeId=79804233149, content=想想科研,五味杂陈, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42332, encodeId=f4fd423329b, content=尽力吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 fatalmelanie

    想想科研,五味杂陈

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1803680, encodeId=6b11180368043, content=<a href='/topic/show?id=2c83e563067' target=_blank style='color:#2F92EE;'>#立项依据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75630, encryptionId=2c83e563067, topicName=立项依据)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Dec 12 09:10:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42397, encodeId=68a04239e28, content=太好了,受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58701660184, createdName=docterdw123, createdTime=Tue Nov 03 10:54:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42355, encodeId=93fb4235581, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 18:13:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42330, encodeId=72be42330ee, content=难呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42331, encodeId=79804233149, content=想想科研,五味杂陈, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42332, encodeId=f4fd423329b, content=尽力吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 16:01:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 fatalmelanie

    尽力吧

    0

相关资讯

《国家自然科学基金条例》征求修改意见

关于征求《国家自然科学基金条例》修改意见的通知 《国家自然科学基金条例》(以下简称《条例》)自2007年颁布实施以来,对推动科学基金依法管理和完善科学基金各项法制工作发挥了重要作用。8年多来,《条例》在具体实施过程中不断面临一些新情况和新问题,需要对《条例》的内容进行修改和完善。根据国务院办公厅关于印发《国务院2015年立法工作计划的通知》,《条例》已经列入了2015年国务院立法计划,由

国自然基金申请书最打动评审专家的是什么?

项目摘要是评审人看到的有关项目的最初说明。在评审过程中,评审人把摘要作为整个申请文件的指南,他们对摘要的印象非常关键。一个有说服力且激动人心的摘要会吸引评审人的注意力和兴趣。另外,评审人要求在较短的时间内对很多项目申请书做出评判,而你在项目摘要部分所写的简短、准确、令人印象深刻的话语会使 你的申请脱颖而出。 摘要是展现申请项目特色的地方,是对整个项目精髓的提炼,是项目申请书的核心,

创新点——国自然评审专家挑刺的**

从科学假设衍生出研究内容和目标,接下来提炼的内容便是课题的特色与创新,逻辑思路可谓一脉相承。首先明确:特色与创新来源于科学假设的原创性。我们还是以前面说到的科学假设:在某临床问题所对应的科学问题中,靶标分子X通过介导Y通路(分子)产生Z效应为例来说明。 先问自己,X分子具有Z效应是不是申请人的发现,如果是则此为创新点1; 再问自己,X分子介导Y通路发挥Z效应

话中有话,如何读懂国自然基金评委的背后暗语?

常见评语1、研究基础差,没有相关的实验结果。点评:与本子相关内容,需要有部分实验结果。2、没有SCI(没有SCI的,国青基本上没有希望)。点评:最好有一两篇一作的SCI后再报国青;至于面上,我们的建议是本子相关内容的,一作或者通讯不少于三篇,最好有三分以上的,这是最低配置。3、有些NSFC本子不像一个项目,而是为一个实验,或一篇文章而打造的。点评:借鉴别人的本子,或找NSFC中标的熟人参谋一下

基金:国自然申请中的“科学问题”和“关键问题”

先来说个故事:某校领导拿了几份当年没有获得批准的申请书去国家基金委相关处室“请教”这几项为什么没有批准,希望多了解一点同行的意见,提高学校国家基金项目的命中率。基金委相关处室领导认真查阅了这几份申请书的同行评审意见,说“你们这个研究基础确实较好,对于选题的调研分析也还到位。但关键问题是缺乏对国内外同行研究状况的评述,要让评审人看到选题确实是建立在同行研究的基金上”。所以,认真调研同行的研究状况固然

2015国家自然科学基金,你能看出点儿啥名堂?

早就翘首以待2015年国家自然科学基金申请项目的评审结果出来啦!8月18日国自然官方网站已公布了评审结果,MedSci第一时间也为大家提供了查询系统,网站,手机端,APP等都可快速查询。下面让我们看看各大高效的表现! 历年基金项目分布状况 从上图可以看出,自从2012基金总数量达高峰后,一直维持在稳定状态,即总数量变化不大,每年在36000项左右。 顶尖高校表现依旧强悍 从今年的